Gabriel Mircus

2.1k total citations · 1 hit paper
16 papers, 1.3k citations indexed

About

Gabriel Mircus is a scholar working on Infectious Diseases, Health and Molecular Biology. According to data from OpenAlex, Gabriel Mircus has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Health and 3 papers in Molecular Biology. Recurrent topics in Gabriel Mircus's work include SARS-CoV-2 and COVID-19 Research (5 papers), Antifungal resistance and susceptibility (5 papers) and Vaccine Coverage and Hesitancy (5 papers). Gabriel Mircus is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Antifungal resistance and susceptibility (5 papers) and Vaccine Coverage and Hesitancy (5 papers). Gabriel Mircus collaborates with scholars based in Israel, United States and Austria. Gabriel Mircus's co-authors include Luis Jódar, Eric J. Haas, Sharon Alroy‐Preis, Jo Southern, John M. McLaughlin, Emilia Anis, David L. Swerdlow, Kaijie Pan, Frederick J. Angulo and Yeheskel Levy and has published in prestigious journals such as The Lancet, PLoS ONE and Scientific Reports.

In The Last Decade

Gabriel Mircus

14 papers receiving 1.3k citations

Hit Papers

Impact and effectiveness of mRNA BNT162b2 vaccine against... 2021 2026 2022 2024 2021 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
    2021 1.0k citations Eric J. Haas, Frederick J. Angulo et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabriel Mircus Israel 11 1.0k 531 335 123 122 16 1.3k
Yeheskel Levy Israel 7 961 0.9× 531 1.0× 335 1.0× 89 0.7× 85 0.7× 11 1.2k
Matt D. T. Hitchings United States 14 1.1k 1.0× 259 0.5× 274 0.8× 126 1.0× 108 0.9× 38 1.4k
Carmit Rubin Israel 13 1.1k 1.1× 318 0.6× 207 0.6× 85 0.7× 102 0.8× 28 1.4k
Gregory Barnsley United Kingdom 6 574 0.6× 332 0.6× 266 0.8× 101 0.8× 81 0.7× 8 922
Gang Zeng China 11 1.1k 1.1× 380 0.7× 118 0.4× 234 1.9× 121 1.0× 19 1.3k
Yaling Hu China 10 1.5k 1.4× 478 0.9× 163 0.5× 103 0.8× 203 1.7× 21 1.7k
Madhumita Shrotri United Kingdom 16 1000 1.0× 211 0.4× 231 0.7× 65 0.5× 99 0.8× 31 1.3k
Esma Herzel Israel 9 596 0.6× 222 0.4× 221 0.7× 81 0.7× 111 0.9× 9 1.0k

Countries citing papers authored by Gabriel Mircus

Since Specialization
Citations

This map shows the geographic impact of Gabriel Mircus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Mircus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Mircus more than expected).

Fields of papers citing papers by Gabriel Mircus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Mircus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Mircus. The network helps show where Gabriel Mircus may publish in the future.

Co-authorship network of co-authors of Gabriel Mircus

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Mircus. A scholar is included among the top collaborators of Gabriel Mircus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Mircus. Gabriel Mircus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Wieder-Finesod, Anat, Dafna Yahav, Carmit Rubin, et al.. (2024). Case-fatality rate of invasive pneumococcal disease caused by various serotypes—an analysis of nationwide surveillance data from Israel, 2009–2018. Clinical Microbiology and Infection. 31(2). 226–232.
3.
Haas, Eric J., John M. McLaughlin, Farid Khan, et al.. (2021). Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. The Lancet Infectious Diseases. 22(3). 357–366. 79 indexed citations
4.
Singer, Shepherd Roee, Frederick J. Angulo, David L. Swerdlow, et al.. (2021). Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study. EClinicalMedicine. 42. 101190–101190. 19 indexed citations
5.
Haas, Eric J., Frederick J. Angulo, John M. McLaughlin, et al.. (2021). Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. The Lancet. 397(10287). 1819–1829. 1042 indexed citations breakdown →
6.
Singer, Shepherd Roee, Frederick J. Angulo, David L. Swerdlow, et al.. (2021). Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel. SSRN Electronic Journal. 2 indexed citations
7.
8.
Nahum, Yoav, Gabriel Mircus, Ilana Perelshtein, et al.. (2018). Antibacterial and physical properties of a novel sonochemical-assisted Zn-CuO contact lens nanocoating. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(1). 95–100. 18 indexed citations
9.
Salmon‐Divon, Mali, et al.. (2018). Pathogen Detection Using Frequency Domain Fluorescent Lifetime Measurements. IEEE Transactions on Biomedical Engineering. 65(12). 2731–2741. 8 indexed citations
10.
Michowiz, Shalom, Helen Toledano, Avraham Hirshberg, et al.. (2017). Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with Medulloblastoma. Scientific Reports. 7(1). 3648–3648. 25 indexed citations
11.
Mircus, Gabriel, Nathaniel D. Albert, Shmuel Carmeli, et al.. (2016). Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis. Journal of Antimicrobial Chemotherapy. 71(4). 946–952. 22 indexed citations
12.
Perelshtein, Ilana, Gabriel Mircus, Miriam Ehrenberg, et al.. (2016). Fabrication of a Stable and Efficient Antibacterial Nanocoating of Zn‐CuO on Contact Lenses. ChemNanoMat. 2(6). 547–551. 23 indexed citations
13.
Mircus, Gabriel, Nathaniel D. Albert, Dodo Chikvashvili, et al.. (2015). Identification and Characterization of a Novel Family of Selective Antifungal Compounds (CANBEFs) That Interfere with Fungal Protein Synthesis. Antimicrobial Agents and Chemotherapy. 59(9). 5631–5640. 17 indexed citations
14.
Sharon, Haim, David Amar, Gabriel Mircus, et al.. (2011). PrtT-Regulated Proteins Secreted by Aspergillus fumigatus Activate MAPK Signaling in Exposed A549 Lung Cells Leading to Necrotic Cell Death. PLoS ONE. 6(3). e17509–e17509. 27 indexed citations
15.
Mircus, Gabriel, et al.. (2009). Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutant. Journal of Antimicrobial Chemotherapy. 64(4). 755–763. 12 indexed citations
16.
Shalit, Itamar, Yona Shadkchan, Gabriel Mircus, & Nir Osherov. (2008). In vitrosynergy of caspofungin with licensed and novel antifungal drugs against clinical isolates ofFusariumspp.. Medical Mycology. 47(5). 457–462. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yeheskel Levy Breakdown of academic impact, for papers by Matt D. T. Hitchings Breakdown of academic impact, for papers by Carmit Rubin Breakdown of academic impact, for papers by Gregory Barnsley Breakdown of academic impact, for papers by Gang Zeng Breakdown of academic impact, for papers by Yaling Hu Breakdown of academic impact, for papers by Madhumita Shrotri Breakdown of academic impact, for papers by Esma Herzel
Rankless by CCL
2026